Albertisimo, Mary Grace A.
HRN: 23-21-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2023
CEFUROXIME 750MG (VIAL)
07/22/2023
07/29/2023
IV
1.5 Gram
Q 8 Hours
S/P CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes